NIH─sponsored trial of candidate vaccine to prevent Lassa fever begins enrolling participants
A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore. Lassa fever is a viral haemorrhagic disease that can …